Home / Health / WHO Greenlights New Ebola Vaccine Trials
WHO Greenlights New Ebola Vaccine Trials
4 Nov
Summary
- WHO approved clinical trials for two new Ebola vaccines.
- The vaccines target the Bundibugyo virus strain.
- The ongoing Ebola outbreak has claimed over 5,300 lives.
The World Health Organization (WHO) has advanced the fight against Ebola by approving clinical trials for two promising new vaccine candidates. These trials focus on vaccines specifically developed for the Bundibugyo virus, a strain affecting the Democratic Republic of Congo (DRC).
This initiative is critical as the ongoing Ebola epidemic across Africa has resulted in more than 5,300 deaths, with the vast majority of cases and fatalities occurring in the DRC. The outbreak has seen over 10,444 confirmed cases, reflecting a severe fatality rate exceeding 50 percent.
While these new vaccines are being developed, the WHO emphasizes that proven public health measures remain essential. These include prompt medical care, effective contact tracing, isolation of infected individuals, safe burial practices, and fostering trust with affected communities.
